New inhibitors of a cancer-causing protein may lead to targeted therapeutics
(PhysOrg.com) -- Markus Seeliger, Ph.D., Assistant Professor, Department of Pharmacological Sciences, Stony Brook University School of Medicine, and collaborators at Harvard University, have developed and characterized the ...